Outcomes after emergency department use in patients with cancer receiving chemotherapy in Ontario, Canada: a population-based cohort study
Authors:
- Keerat GrewalKGKeerat Grewal
- Monika K. KrzyzanowskaMKMonika K. Krzyzanowska
- Shelley McLeodSMShelley McLeod
- Bjug BorgundvaagBBBjug Borgundvaag
- Clare L. AtzemaCAClare L. Atzema
- 1 July 2020
- journal article
- research article
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 8 (3) , E496-E505
Abstract
Background: Patients with cancer frequently require emergency medical care during treatment. The objective of this study was to characterize emergency department visits made by patients with cancer receiving chemotherapy and to describe associated outcomes. Methods: This retrospective cohort study used population-based administrative data from Ontario, Canada. Patients aged 18 years and older, with a cancer diagnosis, and who received chemotherapy in the 30 days before being seen in an emergency department between 2013 and 2017 were included. Emergency department discharge diagnosis codes were categorized to identify the most frequent emergency department diagnoses. We examined the proportion of patients admitted to hospital and 30-day mortality. We used logistic regression to identify predictors of hospital admission. Results: We identified 218 459 emergency department visits made by 87 555 patients. The median number of emergency department visits per patient was 2 (interquartile range 1–3). Hematological, gastrointestinal, breast and lung cancer were the most common malignancies represented. The most common emergency department diagnoses were infection or fever (57 036 [26.1%]) and gastrointestinal diagnoses (26 456 [12.2%]). Of all visits, 77 978 (35.7%) resulted in admission to hospital. Thirty-day mortality after an emergency department visit was 9.8%. There was an increased odds of admission among patients who previously received palliative consultation, patients with bone or soft tissue or hematological malignancies, and patients with infection, gastrointestinal, pulmonary, cardiac, weakness or genitourinary and nephrology diagnoses. Interpretation: Patients with cancer frequently used the emergency department during chemotherapy, and 1 in 4 emergency department visits were for infection or fever. These results highlight opportunities to optimize care for certain patients being actively treated for cancer, particularly around infectious complaints.Keywords
This publication has 17 references indexed in Scilit:
- Population-Based Assessment of Emergency Room Visits and Hospitalizations Among Women Receiving Adjuvant Chemotherapy for Early Breast CancerJournal of Oncology Practice, 2015
- Emergency Room Visits and Hospital Admission Rates After Curative Chemotherapy for Breast CancerJournal of Oncology Practice, 2015
- Missed Strokes Using Computed Tomography Imaging in Patients With VertigoStroke, 2015
- A Population-Based Description of Atrial Fibrillation in the Emergency Department, 2002 to 2010Annals of Emergency Medicine, 2013
- Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XVJournal of Clinical Oncology, 2013
- Use of health-care services during chemotherapy for breast cancerEuropean Journal of Cancer, 2012
- Emergency department visits for symptoms experienced by oncology patients: a systematic reviewSupportive Care in Cancer, 2012
- Why Do Patients With Cancer Visit Emergency Departments? Results of a 2008 Population Study in North CarolinaJournal of Clinical Oncology, 2011
- Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective studySupportive Care in Cancer, 2010
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999